{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:28:38Z","timestamp":1790756918112,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nano Convergence"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40580-018-0168-8","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T02:05:14Z","timestamp":1543197914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Therapeutic nanoplatforms and delivery strategies for neurological disorders"],"prefix":"10.1186","volume":"5","author":[{"given":"You Jung","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Gerard","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-2462","authenticated-orcid":false,"given":"Hansang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"168_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","volume":"107","author":"M Koshy","year":"2012","unstructured":"M. Koshy et al., Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J. Neurooncol. 107, 207\u2013212 (2012)","journal-title":"J. Neurooncol."},{"key":"168_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"J. Wang, B.J. Gu, C.L. Masters, Y.-J. Wang, A systemic view of Alzheimer disease\u2014insights from amyloid-\u03b2 metabolism beyond the brain. Nat. Rev. Neurol. 13, 612 (2017)","journal-title":"Nat. Rev. Neurol."},{"key":"168_CR3","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"W. Poewe et al., Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017)","journal-title":"Nat. Rev. Dis. Primers"},{"key":"168_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1017\/S1041610214001963","volume":"27","author":"J Cummings","year":"2015","unstructured":"J. Cummings et al., Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int. Psychogeriat. 27, 7\u201317 (2015)","journal-title":"Int. Psychogeriat."},{"key":"168_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"N.J. Abbott, L. R\u00f6nnb\u00e4ck, E. Hansson, Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat. Rev. Neurosci. 7, 41 (2006)","journal-title":"Nat. Rev. Neurosci."},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH Jong De","year":"2008","unstructured":"W.H. De Jong, P.J.A. Borm, Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 3, 133\u2013149 (2008)","journal-title":"Int. J. Nanomed."},{"key":"168_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-60761-609-2_3","volume-title":"Cancer nanotechnology: methods and protocols (eds Stephen R. Grobmyer & Brij M. Moudgil)","author":"K Greish","year":"2010","unstructured":"K. Greish, Cancer nanotechnology: methods and protocols (eds Stephen R. Grobmyer & Brij M. Moudgil) (Humana Press, New York, 2010), pp. 25\u201337"},{"key":"168_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/ijms19030659","volume":"19","author":"H Mahmud","year":"2018","unstructured":"H. Mahmud et al., Targeting glioblastoma cells expressing CD44 with liposomes encapsulating doxorubicin and displaying Chlorotoxin-IgG Fc fusion protein. Int. J. Mol. Sci. 19, 659 (2018)","journal-title":"Int. J. Mol. Sci."},{"key":"168_CR9","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-06-0480","volume":"5","author":"AB Madhankumar","year":"2006","unstructured":"A.B. Madhankumar, B. Slagle-Webb, A. Mintz, J.M. Sheehan, J.R. Connor, Interleukin-13 receptor\u2014targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol. Cancer Ther. 5, 3162\u20133169 (2006)","journal-title":"Mol. Cancer Ther."},{"key":"168_CR10","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3892\/ol.2014.2449","volume":"8","author":"LI Qin","year":"2014","unstructured":"L.I. Qin et al., A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy. Oncol. Lett. 8, 2000\u20132006 (2014)","journal-title":"Oncol. Lett."},{"key":"168_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/10717544.2017.1344334","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Y. Zhang et al., Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv. 24, 1045\u20131055 (2017)","journal-title":"Drug Deliv."},{"key":"168_CR12","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1016\/j.biomaterials.2012.03.058","volume":"33","author":"H Gao","year":"2012","unstructured":"H. Gao et al., Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 33, 5115\u20135123 (2012)","journal-title":"Biomaterials"},{"key":"168_CR13","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"J. Guo et al., Aptamer-functionalized PEG\u2013PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32, 8010\u20138020 (2011)","journal-title":"Biomaterials"},{"key":"168_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/10611860903046628","volume":"17","author":"N Shah","year":"2009","unstructured":"N. Shah, K. Chaudhari, P. Dantuluri, R.S.R. Murthy, S. Das, Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic\u00aeP85, an in vitro cell line and in vivo biodistribution studies on rat model. J. Drug Target. 17, 533\u2013542 (2009)","journal-title":"J. Drug Target."},{"key":"168_CR15","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1038\/srep16589","volume":"5","author":"B Wang","year":"2015","unstructured":"B. Wang et al., Improved anti-glioblastoma efficacy by IL-13R\u03b12 mediated copolymer nanoparticles loaded with paclitaxel. Sci. Rep. 5, 16589 (2015)","journal-title":"Sci. Rep."},{"key":"168_CR16","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1039\/C4NR04853A","volume":"7","author":"S Dixit","year":"2015","unstructured":"S. Dixit et al., Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale 7, 1782\u20131790 (2015)","journal-title":"Nanoscale"},{"key":"168_CR17","doi-asserted-by":"publisher","first-page":"1605563","DOI":"10.1002\/adma.201605563","volume":"29","author":"C Lee","year":"2017","unstructured":"C. Lee et al., Rabies virus-inspired silica-coated gold nanorods as a photothermal therapeutic platform for treating brain tumors. Adv. Mater. 29, 1605563 (2017)","journal-title":"Adv. Mater."},{"key":"168_CR18","first-page":"3597613","volume":"2017","author":"B Huang","year":"2017","unstructured":"B. Huang et al., Advances in immunotherapy for glioblastoma multiforme. J. Immunol. Res. 2017, 3597613 (2017)","journal-title":"J. Immunol. Res."},{"key":"168_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"A. Kumar, A. Singh, Ekavali, A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol. Rep. 67, 195\u2013203 (2015)","journal-title":"Pharmacol. Rep."},{"key":"168_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"G Neuroinflammation Working","year":"2000","unstructured":"G. Neuroinflammation Working et al., Inflammation and Alzheimer\u2019s disease. Neurobiol. Aging 21, 383\u2013421 (2000)","journal-title":"Neurobiol. Aging"},{"key":"168_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5114\/aoms.2011.20612","volume":"7","author":"PS Aisen","year":"2011","unstructured":"P.S. Aisen et al., Tramiprosate in mild-to-moderate Alzheimer\u2019s disease\u2014a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study). Arch. Med. Sci. 7, 102\u2013111 (2011)","journal-title":"Arch. Med. Sci."},{"key":"168_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/156720510791162377","volume":"7","author":"M Janusz","year":"2010","unstructured":"M. Janusz, A. Zablocka, Colostral proline-rich polypeptides\u2014immunoregulatory properties and prospects of therapeutic use in Alzheimers disease. Curr. Alzheimer Res. 7, 323\u2013333 (2010)","journal-title":"Curr. Alzheimer Res."},{"key":"168_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3233\/JAD-2010-1262","volume":"19","author":"LE Rojo","year":"2010","unstructured":"L.E. Rojo, J. Alzate-Morales, I.N. Saavedra, P. Davies, R.B. Maccioni, Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 19, 573\u2013589 (2010)","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"168_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"R. Kandimalla, P.H. Reddy, Therapeutics of neurotransmitters in Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 57, 1049\u20131069 (2017)","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"168_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.20089","volume":"55","author":"JG Nutt","year":"2004","unstructured":"J.G. Nutt, J.H. Carter, G.J. Sexton, The dopamine transporter: importance in Parkinson\u2019s disease. Ann. Neurol. 55, 766\u2013773 (2004)","journal-title":"Ann. Neurol."},{"key":"168_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"M.G. Spillantini et al., \u03b1-Synuclein in Lewy bodies. Nature 388, 839 (1997)","journal-title":"Nature"},{"key":"168_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1517\/17425247.2011.556616","volume":"8","author":"S Md","year":"2011","unstructured":"S. Md, S. Haque, J.K. Sahni, S. Baboota, J. Ali, New non-oral drug delivery systems for Parkinson\u2019s disease treatment. Exp. Opin. Drug Deliv. 8, 359\u2013374 (2011)","journal-title":"Exp. Opin. Drug Deliv."},{"key":"168_CR28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0140-6736(05)63511-8","volume":"350","author":"Y Agid","year":"1997","unstructured":"Y. Agid et al., Tolcapone, bromocriptine, and Parkinson\u2019s disease. Lancet 350, 712\u2013713 (1997)","journal-title":"Lancet"},{"key":"168_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","volume":"83","author":"B Thanvi","year":"2007","unstructured":"B. Thanvi, N. Lo, T. Robinson, Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment. Postgrad. Med. J. 83, 384\u2013388 (2007)","journal-title":"Postgrad. Med. J."},{"key":"168_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/03639049809082370","volume":"24","author":"NK Jain","year":"1998","unstructured":"N.K. Jain, A.C. Rana, S.K. Jain, Brain drug delivery system bearing dopamine hydrochloride for effective management of Parkinsonism. Drug Dev. Ind. Pharm. 24, 671\u2013675 (1998)","journal-title":"Drug Dev. Ind. Pharm."},{"key":"168_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/1061186X.2011.595490","volume":"20","author":"Y Xiang","year":"2012","unstructured":"Y. Xiang et al., Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the Parkinson\u2019s disease in the MPTP-induced mice model. J. Drug Target. 20, 67\u201375 (2012)","journal-title":"J. Drug Target."},{"key":"168_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6591-5_2","volume-title":"Liposomes: methods and protocols (ed Gerard G. M.. D\u2019Souza)","author":"H Zhang","year":"2017","unstructured":"H. Zhang, Liposomes: methods and protocols (ed Gerard G. M. D\u2019Souza) (Springer, New York, 2017), pp. 17\u201322"},{"key":"168_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0005-2736(79)90085-3","volume":"557","author":"F Olson","year":"1979","unstructured":"F. Olson, C.A. Hunt, F.C. Szoka, W.J. Vail, D. Papahadjopoulos, Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochimica et Biophysica Acta Biomembranes 557, 9\u201323 (1979)","journal-title":"Biochimica et Biophysica Acta Biomembranes"},{"key":"168_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0076-6879(09)65007-2","volume":"465","author":"B Yu","year":"2009","unstructured":"B. Yu, R.J. Lee, L.J. Lee, Microfluidic methods for production of liposomes. Methods Enzymol. 465, 129\u2013141 (2009)","journal-title":"Methods Enzymol."},{"key":"168_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"T.M. Allen, P.R. Cullis, Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 65, 36\u201348 (2013)","journal-title":"Adv. Drug Deliv. Rev."},{"key":"168_CR36","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1073\/pnas.1516524113","volume":"113","author":"R Xie","year":"2016","unstructured":"R. Xie et al., In vivo metabolic labeling of sialoglycans in the mouse brain by using a liposome-assisted bioorthogonal reporter strategy. Proc. Natl. Acad. Sci. 113, 5173 (2016)","journal-title":"Proc. Natl. Acad. Sci."},{"key":"168_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/BF02716840","volume":"6","author":"D Pain","year":"1984","unstructured":"D. Pain, P.K. Das, P. Ghosh, B.K. Bachhawat, Increased circulatory half-life of liposomes after conjunction with dextran. J. Biosci. 6, 811\u2013816 (1984)","journal-title":"J. Biosci."},{"key":"168_CR38","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bbamem.2007.03.027","volume":"1768","author":"JE Adrian","year":"2007","unstructured":"J.E. Adrian et al., A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochimica et Biophysica Acta Biomembranes 1768, 1430\u20131439 (2007)","journal-title":"Biochimica et Biophysica Acta Biomembranes"},{"key":"168_CR39","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2174\/092986707782794005","volume":"14","author":"M Gary-Bobo","year":"2007","unstructured":"M. Gary-Bobo, P. Nird\u00e9, A. Jeanjean, A. Mor\u00e8re, M. Garcia, Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr. Med. Chem. 14, 2945\u20132953 (2007)","journal-title":"Curr. Med. Chem."},{"key":"168_CR40","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/cyto.a.22715","volume":"87","author":"M Dela\u010d","year":"2015","unstructured":"M. Dela\u010d, H. Motaln, H. Ulrich, T.T. Lah, Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma. Cytometry Part A 87, 806\u2013816 (2015)","journal-title":"Cytometry Part A"},{"key":"168_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"L. Sercombe et al., Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015)","journal-title":"Front. Pharmacol."},{"key":"168_CR42","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3404.27031","author":"RJ Lobb","year":"2015","unstructured":"R.J. Lobb et al., Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles (2015). https:\/\/doi.org\/10.3402\/jev.v3404.27031","journal-title":"J. Extracell. Vesicles"},{"key":"168_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"D. Ha, N. Yang, V. Nadithe, Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B 6, 287\u2013296 (2016)","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"168_CR44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"S. Kamerkar et al., Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546, 498 (2017)","journal-title":"Nature"},{"key":"168_CR45","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"X. Zhuang et al., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769\u20131779 (2011)","journal-title":"Mol. Ther."},{"key":"168_CR46","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"D. Sun et al., A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18, 1606\u20131614 (2010)","journal-title":"Mol. Ther."},{"key":"168_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"M.S. Kim et al., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed. Nanotechnol. Biol. Med. 12, 655\u2013664 (2016)","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"168_CR48","doi-asserted-by":"publisher","first-page":"15598","DOI":"10.1039\/C7NR04425A","volume":"9","author":"J Wang","year":"2017","unstructured":"J. Wang et al., The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. Nanoscale 9, 15598\u201315605 (2017)","journal-title":"Nanoscale"},{"key":"168_CR49","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"X. Luan et al., Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol. Sin. 38, 754 (2017)","journal-title":"Acta Pharmacol. Sin."},{"key":"168_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.addr.2012.07.002","volume":"65","author":"D Sun","year":"2013","unstructured":"D. Sun et al., Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv. Drug Deliv. Rev. 65, 342\u2013347 (2013)","journal-title":"Adv. Drug Deliv. Rev."},{"key":"168_CR51","doi-asserted-by":"publisher","first-page":"23978","DOI":"10.1038\/srep23978","volume":"6","author":"MA Rider","year":"2016","unstructured":"M.A. Rider, S.N. Hurwitz, D.G. Meckes Jr., ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci. Rep. 6, 23978 (2016)","journal-title":"Sci. Rep."},{"key":"168_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biomaterials.2016.07.003","volume":"105","author":"DC Watson","year":"2016","unstructured":"D.C. Watson et al., Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105, 195\u2013205 (2016)","journal-title":"Biomaterials"},{"key":"168_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/03602559.2014.958780","volume":"54","author":"A Nasir","year":"2015","unstructured":"A. Nasir, A. Kausar, A. Younus, A review on preparation, properties and applications of polymeric nanoparticle-based materials. Polymer-Plastics Technol. Eng. 54, 325\u2013341 (2015)","journal-title":"Polymer-Plastics Technol. Eng."},{"key":"168_CR54","first-page":"71","volume":"2","author":"P Kothamasu","year":"2012","unstructured":"P. Kothamasu et al., Nanocapsules: the weapons for novel drug delivery systems. BioImpacts 2, 71\u201381 (2012)","journal-title":"BioImpacts"},{"key":"168_CR55","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","volume":"10","author":"T Lin","year":"2016","unstructured":"T. Lin et al., Blood\u2013brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano 10, 9999\u201310012 (2016)","journal-title":"ACS Nano"},{"key":"168_CR56","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1021\/la204944j","volume":"28","author":"AHE Machado","year":"2012","unstructured":"A.H.E. Machado et al., Preparation of calcium alginate nanoparticles using water-in-oil (W\/O) nanoemulsions. Langmuir 28, 4131\u20134141 (2012)","journal-title":"Langmuir"},{"key":"168_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijbiomac.2015.08.006","volume":"81","author":"N Sahoo","year":"2015","unstructured":"N. Sahoo, R.K. Sahoo, N. Biswas, A. Guha, K. Kuotsu, Recent advancement of gelatin nanoparticles in drug and vaccine delivery. Int. J. Biol. Macromol. 81, 317\u2013331 (2015)","journal-title":"Int. J. Biol. Macromol."},{"key":"168_CR58","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3109\/03639045.2014.991400","volume":"41","author":"O Jafarieh","year":"2015","unstructured":"O. Jafarieh et al., Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 41, 1674\u20131681 (2015)","journal-title":"Drug Dev. Ind. Pharm."},{"key":"168_CR59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5607\/en.2014.23.3.246","volume":"23","author":"PY Gambaryan","year":"2014","unstructured":"P.Y. Gambaryan, I.G. Kondrasheva, E.S. Severin, A.A. Guseva, A.A. Kamensky, Increasing the efficiency of Parkinson\u2019s disease treatment using a poly(lactic-co-glycolic acid) (PLGA) based L-DOPA delivery system. Exp. Neurobiol. 23, 246\u2013252 (2014)","journal-title":"Exp. Neurobiol."},{"key":"168_CR60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.freeradbiomed.2013.07.042","volume":"65","author":"MN Tiwari","year":"2013","unstructured":"M.N. Tiwari et al., Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism. Free Radical Biol. Med. 65, 704\u2013718 (2013)","journal-title":"Free Radical Biol. Med."},{"key":"168_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijpharm.2005.01.043","volume":"295","author":"W Lu","year":"2005","unstructured":"W. Lu, Y.-Z. Tan, K.-L. Hu, X.-G. Jiang, Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood\u2013brain barrier. Int. J. Pharm. 295, 247\u2013260 (2005)","journal-title":"Int. J. Pharm."},{"key":"168_CR62","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","volume":"32","author":"H Xin","year":"2011","unstructured":"H. Xin et al., Angiopep-conjugated poly(ethylene glycol)-co-poly(\u03b5-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32, 4293\u20134305 (2011)","journal-title":"Biomaterials"},{"key":"168_CR63","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/mp900306x","volume":"7","author":"RS Mulik","year":"2010","unstructured":"R.S. Mulik, J. M\u00f6nkk\u00f6nen, R.O. Juvonen, K.R. Mahadik, A.R. Paradkar, ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol. Pharm. 7, 815\u2013825 (2010)","journal-title":"Mol. Pharm."},{"key":"168_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/wnan.59","volume":"2","author":"PV Kulkarni","year":"2010","unstructured":"P.V. Kulkarni et al., Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease. Nanomed. Nanobiotechnol. 2, 35\u201347 (2010)","journal-title":"Nanomed. Nanobiotechnol."},{"key":"168_CR65","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.M805956200","volume":"284","author":"L Hasadsri","year":"2009","unstructured":"L. Hasadsri, J. Kreuter, H. Hattori, T. Iwasaki, J.M. George, Functional protein delivery into neurons using polymeric nanoparticles. J. Biol. Chem. 284, 6972\u20136981 (2009)","journal-title":"J. Biol. Chem."},{"key":"168_CR66","doi-asserted-by":"publisher","first-page":"065002","DOI":"10.1088\/1748-6041\/5\/6\/065002","volume":"5","author":"L Jie","year":"2010","unstructured":"L. Jie, Q. Zhiye, W. Shenqi, Z. Lei, Z. Shengmin, A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed. Mater. 5, 065002 (2010)","journal-title":"Biomed. Mater."},{"key":"168_CR67","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1039\/b906556n","volume":"19","author":"S Hornig","year":"2009","unstructured":"S. Hornig, T. Heinze, C.R. Becer, U.S. Schubert, Synthetic polymeric nanoparticles by nanoprecipitation. J. Mater. Chem. 19, 3838\u20133840 (2009)","journal-title":"J. Mater. Chem."},{"key":"168_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1556-276X-7-144","volume":"7","author":"A Akbarzadeh","year":"2012","unstructured":"A. Akbarzadeh, M. Samiei, S. Davaran, Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res. Lett. 7, 144 (2012)","journal-title":"Nanoscale Res. Lett."},{"key":"168_CR69","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/0975-7406.72127","volume":"2","author":"VV Mody","year":"2010","unstructured":"V.V. Mody, R. Siwale, A. Singh, H.R. Mody, Introduction to metallic nanoparticles. J. Pharm. Bioallied Sci. 2, 282\u2013289 (2010)","journal-title":"J. Pharm. Bioallied Sci."},{"key":"168_CR70","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1021\/jp211843g","volume":"116","author":"T Ahn","year":"2012","unstructured":"T. Ahn, J.H. Kim, H.-M. Yang, J.W. Lee, J.-D. Kim, Formation pathways of magnetite nanoparticles by coprecipitation method. J. Phys. Chem. C 116, 6069\u20136076 (2012)","journal-title":"J. Phys. Chem. C"},{"key":"168_CR71","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.3390\/ma6125549","volume":"6","author":"MC Mascolo","year":"2013","unstructured":"M.C. Mascolo, Y. Pei, T.A. Ring, Room temperature co-precipitation synthesis of magnetite nanoparticles in a large pH window with different bases. Materials (Basel, Switzerland) 6, 5549\u20135567 (2013)","journal-title":"Materials (Basel, Switzerland)"},{"key":"168_CR72","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1021\/acsnano.7b00609","volume":"11","author":"M Unni","year":"2017","unstructured":"M. Unni et al., Thermal decomposition synthesis of iron oxide nanoparticles with diminished magnetic dead layer by controlled addition of oxygen. ACS Nano 11, 2284\u20132303 (2017)","journal-title":"ACS Nano"},{"key":"168_CR73","doi-asserted-by":"publisher","first-page":"11142","DOI":"10.1039\/C5NR01651G","volume":"7","author":"R Hufschmid","year":"2015","unstructured":"R. Hufschmid et al., Synthesis of phase-pure and monodisperse iron oxide nanoparticles by thermal decomposition. Nanoscale 7, 11142\u201311154 (2015)","journal-title":"Nanoscale"},{"key":"168_CR74","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1016\/j.matlet.2007.03.024","volume":"61","author":"S Takami","year":"2007","unstructured":"S. Takami et al., Hydrothermal synthesis of surface-modified iron oxide nanoparticles. Mater. Lett. 61, 4769\u20134772 (2007)","journal-title":"Mater. Lett."},{"key":"168_CR75","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1021\/am302883m","volume":"5","author":"H Cai","year":"2013","unstructured":"H. Cai et al., Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl. Mater. Interfaces. 5, 1722\u20131731 (2013)","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"168_CR76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jmatprotec.2007.03.011","volume":"191","author":"AB Chin","year":"2007","unstructured":"A.B. Chin, I.I. Yaacob, Synthesis and characterization of magnetic iron oxide nanoparticles via w\/o microemulsion and Massart\u2019s procedure. J. Mater. Process. Technol. 191, 235\u2013237 (2007)","journal-title":"J. Mater. Process. Technol."},{"key":"168_CR77","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1021\/la0008636","volume":"17","author":"S Santra","year":"2001","unstructured":"S. Santra et al., Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir 17, 2900\u20132906 (2001)","journal-title":"Langmuir"},{"key":"168_CR78","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1021\/la010421+","volume":"17","author":"KVPM Shafi","year":"2001","unstructured":"K.V.P.M. Shafi et al., Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles. Langmuir 17, 5093\u20135097 (2001)","journal-title":"Langmuir"},{"key":"168_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.partic.2010.05.013","volume":"9","author":"A Hassanjani-Roshan","year":"2011","unstructured":"A. Hassanjani-Roshan, M.R. Vaezi, A. Shokuhfar, Z. Rajabali, Synthesis of iron oxide nanoparticles via sonochemical method and their characterization. Particuology 9, 95\u201399 (2011)","journal-title":"Particuology"},{"key":"168_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/cm980742f","volume":"11","author":"C Pascal","year":"1999","unstructured":"C. Pascal, J.L. Pascal, F. Favier, M.L. Elidrissi Moubtassim, C. Payen, Electrochemical synthesis for the control of \u03b3-Fe2O3 nanoparticle size. morphology, microstructure, and magnetic behavior. Chem. Mater. 11, 141\u2013147 (1999)","journal-title":"Chem. Mater."},{"key":"168_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.apsusc.2014.12.098","volume":"336","author":"F Dumitrache","year":"2015","unstructured":"F. Dumitrache et al., Highly magnetic Fe2O3 nanoparticles synthesized by laser pyrolysis used for biological and heat transfer applications. Appl. Surf. Sci. 336, 297\u2013303 (2015)","journal-title":"Appl. Surf. Sci."},{"key":"168_CR82","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1021\/la704019p","volume":"24","author":"AA Bharde","year":"2008","unstructured":"A.A. Bharde et al., Bacteria-mediated precursor-dependent biosynthesis of superparamagnetic iron oxide and iron sulfide nanoparticles. Langmuir 24, 5787\u20135794 (2008)","journal-title":"Langmuir"},{"key":"168_CR83","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1021\/bc7003928","volume":"19","author":"MV Yigit","year":"2008","unstructured":"M.V. Yigit, D. Mazumdar, Y. Lu, MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles. Bioconjug. Chem. 19, 412\u2013417 (2008)","journal-title":"Bioconjug. Chem."},{"key":"168_CR84","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/smll.200700784","volume":"4","author":"C Sun","year":"2008","unstructured":"C. Sun et al., In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 4, 372\u2013379 (2008)","journal-title":"Small"},{"key":"168_CR85","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1158\/0008-5472.CAN-10-1022","volume":"70","author":"CG Hadjipanayis","year":"2010","unstructured":"C.G. Hadjipanayis et al., EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Can. Res. 70, 6303\u20136312 (2010)","journal-title":"Can. Res."},{"key":"168_CR86","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2147\/IJN.S152461","volume":"13","author":"M Shevtsov","year":"2018","unstructured":"M. Shevtsov et al., Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs). Int. J. Nanomed. 13, 1471\u20131482 (2018)","journal-title":"Int. J. Nanomed."},{"key":"168_CR87","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1148\/radiol.2017162759","volume":"284","author":"HE Daldrup-Link Ten","year":"2017","unstructured":"H.E. Ten Daldrup-Link, Things you might not know about iron oxide nanoparticles. Radiology 284, 616\u2013629 (2017)","journal-title":"Radiology"},{"key":"168_CR88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-121171","volume":"34","author":"LO Sillerud","year":"2013","unstructured":"L.O. Sillerud et al., SPION-enhanced magnetic resonance imaging of Alzheimer\u2019s disease plaques in A\u03b2PP\/PS-1 transgenic mouse brain. J. Alzheimer\u2019s Dis. 34, 349\u2013365 (2013)","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"168_CR89","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1021\/acschemneuro.7b00260","volume":"9","author":"T Fern\u00e1ndez","year":"2018","unstructured":"T. Fern\u00e1ndez, A. Mart\u00ednez-Serrano, L. Cuss\u00f3, M. Desco, M. Ramos-G\u00f3mez, Functionalization and characterization of magnetic nanoparticles for the detection of ferritin accumulation in Alzheimer\u2019s disease. ACS Chem. Neurosci. 9, 912\u2013924 (2018)","journal-title":"ACS Chem. Neurosci."},{"key":"168_CR90","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1016\/j.biomaterials.2014.04.063","volume":"35","author":"Z Zhou","year":"2014","unstructured":"Z. Zhou et al., Iron\/iron oxide core\/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 35, 7470\u20137478 (2014)","journal-title":"Biomaterials"},{"key":"168_CR91","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.msec.2017.05.079","volume":"80","author":"A Sood","year":"2017","unstructured":"A. Sood, V. Arora, J. Shah, R.K. Kotnala, T.K. Jain, Multifunctional gold coated iron oxide core-shell nanoparticles stabilized using thiolated sodium alginate for biomedical applications. Mater. Sci. Eng. C 80, 274\u2013281 (2017)","journal-title":"Mater. Sci. Eng. C"},{"key":"168_CR92","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.biomaterials.2007.01.043","volume":"28","author":"TR Pisanic","year":"2007","unstructured":"T.R. Pisanic, J.D. Blackwell, V.I. Shubayev, R.R. Fi\u00f1ones, S. Jin, Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28, 2572\u20132581 (2007)","journal-title":"Biomaterials"},{"key":"168_CR93","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s11095-012-0679-7","volume":"29","author":"MV Yigit","year":"2012","unstructured":"M.V. Yigit, A. Moore, Z. Medarova, Magnetic nanoparticles for cancer diagnosis and therapy. Pharm. Res. 29, 1180\u20131188 (2012)","journal-title":"Pharm. Res."},{"key":"168_CR94","doi-asserted-by":"publisher","first-page":"13939","DOI":"10.1021\/ja074447k","volume":"129","author":"X Ji","year":"2007","unstructured":"X. Ji et al., Size control of gold nanocrystals in citrate reduction: the third role of citrate. J. Am. Chem. Soc. 129, 13939\u201313948 (2007)","journal-title":"J. Am. Chem. Soc."},{"key":"168_CR95","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1021\/la060045z","volume":"22","author":"JDS Newman","year":"2006","unstructured":"J.D.S. Newman, G.J. Blanchard, Formation of gold nanoparticles using amine reducing agents. Langmuir 22, 5882\u20135887 (2006)","journal-title":"Langmuir"},{"key":"168_CR96","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1021\/cm051115a","volume":"17","author":"MK Corbierre","year":"2005","unstructured":"M.K. Corbierre, R.B. Lennox, Preparation of thiol-capped gold nanoparticles by chemical reduction of soluble Au(I)\u2009\u2212\u2009thiolates. Chem. Mater. 17, 5691\u20135696 (2005)","journal-title":"Chem. Mater."},{"key":"168_CR97","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1021\/jp0441588","volume":"109","author":"S Eustis","year":"2005","unstructured":"S. Eustis, H.-Y. Hsu, M.A. El-Sayed, Gold nanoparticle formation from photochemical reduction of Au3+ by continuous excitation in colloidal solutions. A proposed molecular mechanism. J. Phys. Chem. B 109, 4811\u20134815 (2005)","journal-title":"J. Phys. Chem. B"},{"key":"168_CR98","doi-asserted-by":"publisher","first-page":"16572","DOI":"10.1021\/ja803490n","volume":"130","author":"ML Marin","year":"2008","unstructured":"M.L. Marin, K.L. McGilvray, J.C. Scaiano, Photochemical strategies for the synthesis of gold nanoparticles from Au(III) and Au(I) using photoinduced free radical generation. J. Am. Chem. Soc. 130, 16572\u201316584 (2008)","journal-title":"J. Am. Chem. Soc."},{"key":"168_CR99","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/cphc.201402697","volume":"16","author":"NSM Yusof","year":"2015","unstructured":"N.S.M. Yusof, M. Ashokkumar, Sonochemical synthesis of gold nanoparticles by using high intensity focused ultrasound. ChemPhysChem 16, 775\u2013781 (2015)","journal-title":"ChemPhysChem"},{"key":"168_CR100","first-page":"5415","volume":"9","author":"F Correard","year":"2014","unstructured":"F. Correard et al., Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications. Int. J. Nanomed. 9, 5415\u20135430 (2014)","journal-title":"Int. J. Nanomed."},{"key":"168_CR101","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41467-017-00970-1","volume":"8","author":"Q Yao","year":"2017","unstructured":"Q. Yao et al., Understanding seed-mediated growth of gold nanoclusters at molecular level. Nat. Commun. 8, 927 (2017)","journal-title":"Nat. Commun."},{"key":"168_CR102","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.3390\/molecules14104284","volume":"14","author":"V S\u00e1ez","year":"2009","unstructured":"V. S\u00e1ez, J.T. Mason, Sonoelectrochemical synthesis of nanoparticles. Molecules 14, 4284 (2009)","journal-title":"Molecules"},{"key":"168_CR103","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1021\/jp057170o","volume":"110","author":"PK Jain","year":"2006","unstructured":"P.K. Jain, K.S. Lee, I.H. El-Sayed, M.A. El-Sayed, Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B 110, 7238\u20137248 (2006)","journal-title":"J. Phys. Chem. B"},{"key":"168_CR104","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1073\/pnas.0813327106","volume":"106","author":"CL Zavaleta","year":"2009","unstructured":"C.L. Zavaleta et al., Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 106, 13511\u201313516 (2009)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"168_CR105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11481-016-9690-9","volume":"12","author":"H Hirschberg","year":"2017","unstructured":"H. Hirschberg, S.J. Madsen, Cell mediated photothermal therapy of brain tumors. J. Neuroimmune Pharmacol. 12, 99\u2013106 (2017)","journal-title":"J. Neuroimmune Pharmacol."},{"key":"168_CR106","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/cr068445e","volume":"108","author":"S Laurent","year":"2008","unstructured":"S. Laurent et al., Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064\u20132110 (2008)","journal-title":"Chem. Rev."},{"key":"168_CR107","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"W.M. Pardridge, The blood\u2013brain barrier: bottleneck in brain drug development. NeuroRx 2, 3\u201314 (2005)","journal-title":"NeuroRx"},{"key":"168_CR108","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40005-016-0250-3","volume":"46","author":"ES Lee","year":"2016","unstructured":"E.S. Lee, Y.S. Youn, Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. J. Pharm. Invest. 46, 305\u2013315 (2016)","journal-title":"J. Pharm. Invest."},{"key":"168_CR109","doi-asserted-by":"publisher","first-page":"22595","DOI":"10.1038\/srep22595","volume":"6","author":"NM Smith","year":"2016","unstructured":"N.M. Smith et al., An unexpected transient breakdown of the blood brain barrier triggers passage of large intravenously administered nanoparticles. Sci. Rep. 6, 22595 (2016)","journal-title":"Sci. Rep."},{"key":"168_CR110","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.7150\/thno.19365","volume":"7","author":"F-F An","year":"2017","unstructured":"F.-F. An, X.-H. Zhang, Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics 7, 3667\u20133689 (2017)","journal-title":"Theranostics"},{"key":"168_CR111","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","volume":"71","author":"K Ulbrich","year":"2009","unstructured":"K. Ulbrich, T. Hekmatara, E. Herbert, J. Kreuter, Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB). Eur. J. Pharm. Biopharm. 71, 251\u2013256 (2009)","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"168_CR112","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/10611861003734001","volume":"19","author":"K Ulbrich","year":"2011","unstructured":"K. Ulbrich, T. Knobloch, J. Kreuter, Targeting the insulin receptor: nanoparticles for drug delivery across the blood\u2013brain barrier (BBB). J. Drug Target. 19, 125\u2013132 (2011)","journal-title":"J. Drug Target."},{"key":"168_CR113","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"S.G. Patching, Glucose transporters at the blood\u2013brain barrier: function, regulation and gateways for drug delivery. Mol. Neurobiol. 54, 1046\u20131077 (2017)","journal-title":"Mol. Neurobiol."},{"key":"168_CR114","doi-asserted-by":"publisher","first-page":"e81043","DOI":"10.1371\/journal.pone.0081043","volume":"8","author":"R Gromnicova","year":"2013","unstructured":"R. Gromnicova et al., Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS ONE 8, e81043 (2013)","journal-title":"PLoS ONE"},{"key":"168_CR115","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","volume":"35","author":"X Jiang","year":"2014","unstructured":"X. Jiang et al., Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials 35, 518\u2013529 (2014)","journal-title":"Biomaterials"},{"key":"168_CR116","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1088\/0031-9155\/55\/15\/013","volume":"55","author":"L Ji","year":"2010","unstructured":"L. Ji et al., A novel functional CT contrast agent for molecular imaging of cancer. Phys. Med. Biol. 55, 4389 (2010)","journal-title":"Phys. Med. Biol."},{"key":"168_CR117","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.crad.2014.05.112","volume":"69","author":"G Feng","year":"2014","unstructured":"G. Feng, B. Kong, J. Xing, J. Chen, Enhancing multimodality functional and molecular imaging using glucose-coated gold nanoparticles. Clin. Radiol. 69, 1105\u20131111 (2014)","journal-title":"Clin. Radiol."},{"key":"168_CR118","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/bj1310211","volume":"131","author":"JEG Barnett","year":"1973","unstructured":"J.E.G. Barnett, G.D. Holman, K.A. Munday, Structural requirements for binding to the sugar-transport system of the human erythrocyte. Biochem. J. 131, 211\u2013221 (1973)","journal-title":"Biochem. J."},{"key":"168_CR119","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","volume":"8","author":"Y Anraku","year":"2017","unstructured":"Y. Anraku et al., Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat. Commun. 8, 1001 (2017)","journal-title":"Nat. Commun."},{"key":"168_CR120","doi-asserted-by":"publisher","first-page":"703545","DOI":"10.1155\/2013\/703545","volume":"2013","author":"G Xiao","year":"2013","unstructured":"G. Xiao, L.-S. Gan, Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol. 2013, 703545 (2013)","journal-title":"Int. J. Cell Biol."},{"key":"168_CR121","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"C. Saraiva et al., Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases. J. Control. Release 235, 34\u201347 (2016)","journal-title":"J. Control. Release"},{"key":"168_CR122","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","volume":"9","author":"FC Lam","year":"2018","unstructured":"F.C. Lam et al., Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nat. Commun. 9, 1991 (2018)","journal-title":"Nat. Commun."},{"key":"168_CR123","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1073\/pnas.1307152110","volume":"110","author":"DT Wiley","year":"2013","unstructured":"D.T. Wiley, P. Webster, A. Gale, M.E. Davis, Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc. Natl. Acad. Sci. U.S.A. 110, 8662\u20138667 (2013)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"168_CR124","doi-asserted-by":"publisher","first-page":"10396","DOI":"10.1038\/s41598-017-11220-1","volume":"7","author":"KB Johnsen","year":"2017","unstructured":"K.B. Johnsen et al., Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. Sci. Rep. 7, 10396 (2017)","journal-title":"Sci. Rep."},{"key":"168_CR125","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/bit.21764","volume":"100","author":"RJ Boado","year":"2007","unstructured":"R.J. Boado, Y. Zhang, Y. Zhang, Y. Wang, W.M. Pardridge, GDNF fusion protein for targeted-drug delivery across the human blood\u2013brain barrier. Biotechnol. Bioeng. 100, 387\u2013396 (2007)","journal-title":"Biotechnol. Bioeng."},{"key":"168_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","volume":"24","author":"P Kumari","year":"2016","unstructured":"P. Kumari, B. Ghosh, S. Biswas, Nanocarriers for cancer-targeted drug delivery. J. Drug Target. 24, 179\u2013191 (2016)","journal-title":"J. Drug Target."},{"key":"168_CR127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","volume":"3","author":"S Senapati","year":"2018","unstructured":"S. Senapati, A.K. Mahanta, S. Kumar, P. Maiti, Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transd. Targeted Ther. 3, 7 (2018)","journal-title":"Signal Transd. Targeted Ther."},{"key":"168_CR128","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1369-7021(05)71033-6","volume":"8","author":"TM Fahmy","year":"2005","unstructured":"T.M. Fahmy, P.M. Fong, A. Goyal, W.M. Saltzman, Targeted for drug delivery. Mater. Today 8, 18\u201326 (2005)","journal-title":"Mater. Today"},{"key":"168_CR129","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","volume":"153","author":"YH Bae","year":"2011","unstructured":"Y.H. Bae, K. Park, Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Release 153, 198\u2013205 (2011)","journal-title":"J. Control. Release"},{"key":"168_CR130","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1021\/mp400751g","volume":"11","author":"H Gao","year":"2014","unstructured":"H. Gao et al., RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol. Pharm. 11, 1042\u20131052 (2014)","journal-title":"Mol. Pharm."},{"key":"168_CR131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/nano6010003","volume":"6","author":"S Wang","year":"2016","unstructured":"S. Wang, Y. Meng, C. Li, M. Qian, R. Huang, Receptor-mediated drug delivery systems targeting to glioma. Nanomaterials 6, 3 (2016)","journal-title":"Nanomaterials"},{"key":"168_CR132","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/1471-2407-11-359","volume":"11","author":"M Kawamoto","year":"2011","unstructured":"M. Kawamoto, T. Horibe, M. Kohno, K. Kawakami, A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer 11, 359 (2011)","journal-title":"BMC Cancer"},{"key":"168_CR133","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1016\/j.biomaterials.2013.08.039","volume":"34","author":"B Zhang","year":"2013","unstructured":"B. Zhang et al., LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials 34, 9171\u20139182 (2013)","journal-title":"Biomaterials"},{"key":"168_CR134","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biomaterials.2010.09.024","volume":"32","author":"H Xie","year":"2011","unstructured":"H. Xie et al., Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials 32, 495\u2013502 (2011)","journal-title":"Biomaterials"},{"key":"168_CR135","doi-asserted-by":"publisher","first-page":"19850","DOI":"10.1021\/am505223t","volume":"6","author":"N Chen","year":"2014","unstructured":"N. Chen et al., Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas. ACS Appl. Mater. Interfaces. 6, 19850\u201319857 (2014)","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"168_CR136","doi-asserted-by":"publisher","first-page":"34158","DOI":"10.18632\/oncotarget.8926","volume":"7","author":"SL Hayward","year":"2016","unstructured":"S.L. Hayward, C.L. Wilson, S. Kidambi, Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Oncotarget 7, 34158\u201334171 (2016)","journal-title":"Oncotarget"},{"key":"168_CR137","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1038\/srep07979","volume":"5","author":"A Soeda","year":"2015","unstructured":"A. Soeda et al., The evidence of glioblastoma heterogeneity. Sci. Rep. 5, 7979 (2015)","journal-title":"Sci. Rep."},{"key":"168_CR138","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/chem.201404562","volume":"21","author":"N Gao","year":"2014","unstructured":"N. Gao, H. Sun, K. Dong, J. Ren, Gold-nanoparticle-based multifunctional amyloid-\u03b2 inhibitor against Alzheimer\u2019s disease. Chem. Eur. J. 21, 829\u2013835 (2014)","journal-title":"Chem. Eur. J."},{"key":"168_CR139","first-page":"1675","volume":"12","author":"J Pansieri","year":"2017","unstructured":"J. Pansieri et al., Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting. Nanomed. Nanotechnol. Biol. Med. 12, 1675\u20131687 (2017)","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"168_CR140","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s11095-008-9600-9","volume":"25","author":"M Ramakrishnan","year":"2008","unstructured":"M. Ramakrishnan et al., Selective contrast enhancement of individual Alzheimer\u2019s disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar A\u03b242 for magnetic resonance molecular imaging. Pharm. Res. 25, 1861\u20131872 (2008)","journal-title":"Pharm. Res."},{"key":"168_CR141","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12951-016-0212-y","volume":"14","author":"M Plissonneau","year":"2016","unstructured":"M. Plissonneau et al., Gd-nanoparticles functionalization with specific peptides for \u00df-amyloid plaques targeting. J. Nanobiotechnol. 14, 60 (2016)","journal-title":"J. Nanobiotechnol."},{"key":"168_CR142","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","volume":"35","author":"C Zhang","year":"2014","unstructured":"C. Zhang et al., Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice. Biomaterials 35, 456\u2013465 (2014)","journal-title":"Biomaterials"},{"key":"168_CR143","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.0b013e31827b90d1","volume":"80","author":"D Besong-Agbo","year":"2013","unstructured":"D. Besong-Agbo et al., Naturally occurring \u03b1-synuclein autoantibody levels are lower in patients with Parkinson disease. Neurology 80, 169\u2013175 (2013)","journal-title":"Neurology"},{"key":"168_CR144","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1021\/ac048691v","volume":"77","author":"R Baron","year":"2005","unstructured":"R. Baron, M. Zayats, I. Willner, Dopamine-, l-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: assays for the detection of neurotransmitters and of tyrosinase activity. Anal. Chem. 77, 1566\u20131571 (2005)","journal-title":"Anal. Chem."},{"key":"168_CR145","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00604-015-1509-5","volume":"182","author":"Y Xu","year":"2015","unstructured":"Y. Xu, X. Hun, F. Liu, X. Wen, X. Luo, Aptamer biosensor for dopamine based on a gold electrode modified with carbon nanoparticles and thionine labeled gold nanoparticles as probe. Microchim. Acta 182, 1797\u20131802 (2015)","journal-title":"Microchim. Acta"},{"key":"168_CR146","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2009.09.032","volume":"290","author":"R Huang","year":"2010","unstructured":"R. Huang et al., Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model. J. Neurol. Sci. 290, 123\u2013130 (2010)","journal-title":"J. Neurol. Sci."},{"key":"168_CR147","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","volume":"240","author":"F Zhang","year":"2016","unstructured":"F. Zhang, Y.-A. Lin, S. Kannan, R.M. Kannan, Targeting specific cells in the brain with nanomedicines for CNS therapies. J. Controlled Release 240, 212\u2013226 (2016)","journal-title":"J. Controlled Release"},{"key":"168_CR148","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","volume":"12","author":"L You","year":"2018","unstructured":"L. You et al., Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in parkinsonian mice. ACS Nano 12, 4123\u20134139 (2018)","journal-title":"ACS Nano"},{"key":"168_CR149","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/pbc.20803","volume":"48","author":"AM Donson","year":"2007","unstructured":"A.M. Donson, S.O. Addo-Yobo, M.H. Handler, L. Gore, N.K. Foreman, MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr. Blood Cancer 48, 403\u2013407 (2007)","journal-title":"Pediatr. Blood Cancer"},{"key":"168_CR150","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.bjc.6605225","volume":"101","author":"O Martinho","year":"2009","unstructured":"O. Martinho et al., Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br. J. Cancer 101, 973\u2013982 (2009)","journal-title":"Br. J. Cancer"},{"key":"168_CR151","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/cncr.28968","volume":"121","author":"JIL Bastien","year":"2014","unstructured":"J.I.L. Bastien, K.A. McNeill, H.A. Fine, Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. Cancer 121, 502\u2013516 (2014)","journal-title":"Cancer"},{"key":"168_CR152","doi-asserted-by":"crossref","first-page":"16384","DOI":"10.18632\/oncotarget.7650","volume":"7","author":"J Cai","year":"2016","unstructured":"J. Cai et al., Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas. Oncotarget 7, 16384\u201316395 (2016)","journal-title":"Oncotarget"},{"key":"168_CR153","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1158\/1535-7163.MCT-14-1078","volume":"14","author":"KJ Hamblett","year":"2015","unstructured":"K.J. Hamblett et al., AMG 595, an anti-EGFRvIII antibody-drug conjugate, induces potent antitumor activity against EGFRvIII-expressing glioblastoma. Mol. Cancer Ther. 14, 1614\u20131624 (2015)","journal-title":"Mol. Cancer Ther."},{"key":"168_CR154","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.apsb.2014.12.006","volume":"5","author":"H Tong","year":"2015","unstructured":"H. Tong, K. Lou, W. Wang, Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer\u05f3s disease. Acta Pharmaceutica Sinica B 5, 25\u201333 (2015)","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"168_CR155","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1570159X14666151230124904","volume":"14","author":"MS Gunay","year":"2016","unstructured":"M.S. Gunay, A.Y. Ozer, S. Chalon, Drug delivery systems for imaging and therapy of Parkinson\u2019s disease. Curr. Neuropharmacol. 14, 376\u2013391 (2016)","journal-title":"Curr. Neuropharmacol."},{"key":"168_CR156","first-page":"337","volume":"9","author":"TT Sibov","year":"2014","unstructured":"T.T. Sibov et al., Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking. Int. J. Nanomed. 9, 337\u2013350 (2014)","journal-title":"Int. J. Nanomed."},{"key":"168_CR157","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.nano.2018.01.020","volume":"14","author":"K Hu","year":"2018","unstructured":"K. Hu et al., Neuroprotective effect of gold nanoparticles composites in Parkinson\u2019s disease model. Nanomed. Nanotechnol. Biol. Med. 14, 1123\u20131136 (2018)","journal-title":"Nanomed. Nanotechnol. Biol. Med."}],"container-title":["Nano Convergence"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40580-018-0168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40580-018-0168-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40580-018-0168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T19:20:14Z","timestamp":1605468014000},"score":1,"resource":{"primary":{"URL":"https:\/\/nanoconvergencejournal.springeropen.com\/articles\/10.1186\/s40580-018-0168-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/s40580-018-0168-8","relation":{},"ISSN":["2196-5404"],"issn-type":[{"value":"2196-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}